Nucleoside-Sparing Regimens With Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue.

ABSTRACT:

SUBMITTER: Karris MY 

PROVIDER: S-EPMC4867124 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature